Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.882 |
High Similarity |
NPD3817 |
Phase 2 |
0.8706 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8614 |
High Similarity |
NPD6232 |
Discontinued |
0.8571 |
High Similarity |
NPD7473 |
Discontinued |
0.8537 |
High Similarity |
NPD3882 |
Suspended |
0.8528 |
High Similarity |
NPD2801 |
Approved |
0.8512 |
High Similarity |
NPD6166 |
Phase 2 |
0.8512 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8512 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8466 |
Intermediate Similarity |
NPD1934 |
Approved |
0.843 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8412 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8382 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8373 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8363 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8354 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8314 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8313 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8261 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8261 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8253 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8232 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8208 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8199 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8193 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8111 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8084 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8049 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8046 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD37 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7988 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7963 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7962 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7941 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7907 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD919 |
Approved |
0.7886 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7849 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7812 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7684 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7657 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7657 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7616 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7611 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7607 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7561 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7516 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7515 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7453 |
Intermediate Similarity |
NPD943 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7449 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7449 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7432 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7418 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7375 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD7697 |
Approved |
0.732 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5353 |
Approved |
0.731 |
Intermediate Similarity |
NPD920 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7282 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7282 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7263 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7263 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7261 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7193 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7174 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7907 |
Approved |
0.715 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7801 |
Approved |
0.715 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7127 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7087 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7073 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD1933 |
Approved |
0.6988 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6988 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6982 |
Remote Similarity |
NPD5762 |
Approved |
0.6982 |
Remote Similarity |
NPD5763 |
Approved |
0.6982 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6978 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.697 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.697 |
Remote Similarity |
NPD7680 |
Approved |
0.6954 |
Remote Similarity |
NPD3452 |
Approved |
0.6954 |
Remote Similarity |
NPD3450 |
Approved |
0.6952 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6949 |
Remote Similarity |
NPD6385 |
Approved |
0.6949 |
Remote Similarity |
NPD6386 |
Approved |
0.6935 |
Remote Similarity |
NPD4583 |
Approved |
0.6935 |
Remote Similarity |
NPD4582 |
Approved |
0.6932 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6923 |
Remote Similarity |
NPD5408 |
Approved |
0.6923 |
Remote Similarity |
NPD5404 |
Approved |
0.6923 |
Remote Similarity |
NPD5406 |
Approved |
0.6923 |
Remote Similarity |
NPD5405 |
Approved |
0.6909 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6909
|
Remote Similarity |
NPD3764 |
Approved |